Respiratory Infections News

Treatment with convalescent plasma reduced 28-day mortality among adults undergoing mechanical ventilation for COVID-19-induced acute respiratory distress syndrome, according to results published in The New England Journal of Medicine.

The FDA is set to review what could be the country’s first self-administered influenza vaccine.

An analysis of online conversations among health care professionals on social media during September revealed mixed reactions toward newly updated messenger RNA COVID-19 vaccines.

BOSTON — White and Black patients in rural areas face an increased risk for hospital-associated infections, and Black rural patients experience the highest risks for ICU admission an in-hospital death, researchers reported at IDWeek.

BOSTON — Sub-Saharan African countries supported by the U.S. President’s Emergency Plan for AIDS Relief, or PEPFAR, tested for COVID-19 at three times the rate of non-PEPFAR nations, according to data presented at IDWeek.

A new study links some neurocognitive symptoms of long COVID to persistent SARS-CoV-2 infection in the gut, which triggers a series of reactions that lowers serotonin levels.

Nirsevimab, a monoclonal antibody recently approved to prevent respiratory syncytial virus-associated lower respiratory disease in newborns and infants, may protect longer than an RSV season, researchers reported at IDWeek.

People infected with COVID-19 have a higher risk of cardiovascular/cerebrovascular complications. However, researchers found that these risks can be reduced with vaccination and boosting.

BOSTON — The Infectious Diseases Society of America is focused on growing the ID workforce and increasing opportunities for its members, its new president told Healio at IDWeek.

Vaccine mandates played a significant role in boosting influenza vaccination rates during the 2020-2021 influenza season, researchers reported in Pediatrics.